1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Nasal Polyposis Global Clinical Trials Review, H2, 2015

Nasal Polyposis Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 70 pages

Nasal Polyposis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Nasal Polyposis Global Clinical Trials Review, H2, 2015" provides an overview of Nasal Polyposis clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Polyposis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Nasal Polyposis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nasal Polyposis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Nasal Polyposis 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Nasal Polyposis Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Sanofi 27
Clinical Trial Overview of Sanofi 27
Regeneron Pharmaceuticals, Inc. 28
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 28
Optinose US Inc. 29
Clinical Trial Overview of Optinose US Inc. 29
SC Clinical Research, Inc 30
Clinical Trial Overview of SC Clinical Research, Inc 30
PARI Medical Holding GmbH 31
Clinical Trial Overview of PARI Medical Holding GmbH 31
Optimed Research, LTD. 32
Clinical Trial Overview of Optimed Research, LTD. 32
Merck and Co., Inc. 33
Clinical Trial Overview of Merck and Co., Inc. 33
Intersect ENT Inc. 34
Clinical Trial Overview of Intersect ENT Inc. 34
GlaxoSmithKline Plc 35
Clinical Trial Overview of GlaxoSmithKline Plc 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of Top Institutes / Government 37
Hamedan University of Medical Sciences 37
Clinical Trial Overview of Hamedan University of Medical Sciences 37
Massachusetts General Hospital 38
Clinical Trial Overview of Massachusetts General Hospital 38
Ghent University Hospital 39
Clinical Trial Overview of Ghent University Hospital 39
Isfahan University of Medical Sciences 40
Clinical Trial Overview of Isfahan University of Medical Sciences 40
Johannes Gutenberg University Mainz 41
Clinical Trial Overview of Johannes Gutenberg University Mainz 41
St. Elizabeth's Medical Center 42
Clinical Trial Overview of St. Elizabeth's Medical Center 42
University of Alberta 43
Clinical Trial Overview of University of Alberta 43
Five Key Clinical Profiles 44
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Nasal Polyposis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Nasal Polyposis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nasal Polyposis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Nasal Polyposis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Nasal Polyposis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Nasal Polyposis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14
Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Nasal Polyposis Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Nasal Polyposis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Nasal Polyposis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Nasal Polyposis Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Nasal Polyposis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Nasal Polyposis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Nasal Polyposis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Nasal Polyposis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Nasal Polyposis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 27
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 28
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Optinose US Inc., 2015* 29
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by SC Clinical Research, Inc, 2015* 30
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by PARI Medical Holding GmbH, 2015* 31
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Optimed Research, LTD., 2015* 32
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 33
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Intersect ENT Inc., 2015* 34
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 35
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 36
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamedan University of Medical Sciences, 2015* 37
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 39
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 40
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johannes Gutenberg University Mainz, 2015* 41
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Elizabeth's Medical Center, 2015* 42
Nasal Polyposis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2015* 43

List of Figures
Nasal Polyposis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Nasal Polyposis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nasal Polyposis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Nasal Polyposis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Nasal Polyposis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Nasal Polyposis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14
Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Nasal Polyposis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Nasal Polyposis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Nasal Polyposis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Nasal Polyposis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Nasal Polyposis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Nasal Polyposis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Nasal Polyposis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Nasal Polyposis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Nasal Polyposis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Nasal Polyposis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.